A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy.
about
Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.MicroRNA-190b confers radio-sensitivity through negative regulation of Bcl-2 in gastric cancer cells.MicroRNA-744 promotes cell apoptosis via targeting B cell lymphoma-2 in gastric cancer cell line SGC-7901
P2860
A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A Phase II prospective nonrand ...... with concurrent chemotherapy.
@ast
A Phase II prospective nonrand ...... with concurrent chemotherapy.
@en
type
label
A Phase II prospective nonrand ...... with concurrent chemotherapy.
@ast
A Phase II prospective nonrand ...... with concurrent chemotherapy.
@en
prefLabel
A Phase II prospective nonrand ...... with concurrent chemotherapy.
@ast
A Phase II prospective nonrand ...... with concurrent chemotherapy.
@en
P2093
P2860
P356
P1476
A Phase II prospective nonrand ...... with concurrent chemotherapy.
@en
P2093
Jianyang Wang
Shulian Wang
Weihu Wang
Yanru Feng
Yexiong Li
P2860
P304
P356
10.2147/OTT.S91586
P407
P577
2016-05-05T00:00:00Z